Company Overview of VAYA Pharma Inc.
VAYA Pharma Inc., a specialty pharmaceutical company, engages in the discovery, development, manufacture, and marketing of natural lipids based medicines. The company offers Vayarol, a formula of phytosterol esters of Omega-3 fatty acids to reduce various cardiovascular disease (CVD) risk factors; Vayacog, a formula of phosphatidylserine (PS) improved with docosahexaenoic acid; and Vayarin, a formula of PS improved with Omega-3 long-chain polyunsaturated fatty acids. It provides its medicines for various therapeutic segments, such as ADHD, hypertriglyceridemia, and memory impairment. The company is based in Migdal HaEmeq, Israel. VAYA Pharma Inc. operates as a subsidiary of Enzymotec, Ltd.
Sagee 2000 Industrial Park
Migdal HaEmeq, 23106
972 7 47177177
Key Executives for VAYA Pharma Inc.
VAYA Pharma Inc. Key Developments
Similar Private Companies By Industry
|3PLW Ltd.||Middle East/Africa|
|Accelerated Evolution Biotechnologies Ltd||Middle East/Africa|
|Adante Ltd.||Middle East/Africa|
|Advanced Biotechnology Ltd.||Middle East/Africa|
|Advanced Medical Analysis (AMA) Ltd.||Middle East/Africa|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact VAYA Pharma Inc., please visit www.vayapharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.